GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) » Definitions » Price-to-Funds-From-Operations

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Price-to-Funds-From-Operations : (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hubei Biocause Heilen Pharmaceutical Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Business Description

Traded in Other Exchanges
N/A
Address
No. 122, Yangwan Road, Dadao District, Jingmen High-tech Zone, Hubei Province, Jingmen, CHN, 448000
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.